PLoS ONE (Jan 2017)

Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells.

  • Haikun Liu,
  • Dongsheng Guo,
  • Aynisahan Ruzi,
  • Yan Chen,
  • Tingcai Pan,
  • Fan Yang,
  • Jialiang Li,
  • Kecheng Xu,
  • Tiancheng Zhou,
  • Dajiang Qin,
  • Yin-Xiong Li

DOI
https://doi.org/10.1371/journal.pone.0179353
Journal volume & issue
Vol. 12, no. 6
p. e0179353

Abstract

Read online

Human induced pluripotent stem cells (hiPSCs) may provide potential resource for regenerative medicine research, including generation of insulin-producing cells for diabetes research and insulin production. Testosterone (T) is an androgen hormone which promotes protein synthesis and improves the management of type 2 diabetes in clinical studies. Concurrently, co-existed hyperandrogenism and hyperinsulinism is frequently observed in polycystic ovary syndrome, congenital adrenal hyperplasia and some of Wermer's syndrome. However, the relationship among androgens, insulin and the differentiation of pancreatic β cells is still not fully clear. Here we find that T improves the differentiation efficiency of insulin-producing cells from hiPSCs. The addition of T into routine differentiation formula for pancreatic β cells increases the differentiation efficiency from 12% to 35%. The administration of T promotes the expression of key genes associated with β cells differentiation including NGN3, NEUROD1 and INS. This finding benefits the ongoing process to optimize the differentiation protocol of pancreatic β cells from hiPSCs, and provides some degree of understanding the clinical management of T for type 2 diabetes.